TRISTEL PLC (TSTL) — Interim Results

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the TRISTEL PLC Interim Results Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. Before we begin, I would like to submit the following poll, and I would now like to hand you over to the management team of TRISTEL. Matt, morning to you. Hi. Good morning. Thank you for joining us today for TRISTEL's interim results, h one, financial year 2026. I'm joined today by, Anna Russell, TRISTEL's CFO, and Julia Shapanova, who's TRISTEL's executive director. Appreciate that, Yulia may be a new name to some of the investors that are joining us today. So let me just give a a brief background into her. She's been executive director at TRISTEL, and president of our US subsidiary. This year actually marks her twentieth year, with TRISTEL, so she's a very long serving member of the team. Yulia has, really, been an instrumental part of the the leadership team. She executed the scientific program with the FDA, securing our US market entry, and really has been leading our commercial efforts with working on the launch of our two key products there, ultrasound and OPH. As we go through the presentation, Julia will be updating you all on the progress we're making in The USA. So that being said, let me just also take a moment to acknowledge, the announcement that was made, earlier this year that I will be stepping down as chief executive at the end of the financial year. This was a deeply considered, personal decision. TRISTEL is a business with, exceptional people, a strong depth in its leadership, and a very strategic, clear strateg...